These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345 [TBL] [Abstract][Full Text] [Related]
5. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. Bradshaw AC; Parker AL; Duffy MR; Coughlan L; van Rooijen N; Kähäri VM; Nicklin SA; Baker AH PLoS Pathog; 2010 Oct; 6(10):e1001142. PubMed ID: 20949078 [TBL] [Abstract][Full Text] [Related]
6. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats. Nicol CG; Graham D; Miller WH; White SJ; Smith TA; Nicklin SA; Stevenson SC; Baker AH Mol Ther; 2004 Aug; 10(2):344-54. PubMed ID: 15294181 [TBL] [Abstract][Full Text] [Related]
7. Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor. Lenaerts L; Daelemans D; Geukens N; De Clercq E; Naesens L FEBS Lett; 2006 Jul; 580(16):3937-42. PubMed ID: 16806202 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162 [TBL] [Abstract][Full Text] [Related]
10. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574 [TBL] [Abstract][Full Text] [Related]
11. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866 [TBL] [Abstract][Full Text] [Related]
12. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo. Denby L; Work LM; Graham D; Hsu C; von Seggern DJ; Nicklin SA; Baker AH Hum Gene Ther; 2004 Nov; 15(11):1054-64. PubMed ID: 15610606 [TBL] [Abstract][Full Text] [Related]
13. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus). Alba R; Bradshaw AC; Mestre-Francés N; Verdier JM; Henaff D; Baker AH Gene Ther; 2012 Jan; 19(1):109-13. PubMed ID: 21677690 [TBL] [Abstract][Full Text] [Related]
14. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000 [TBL] [Abstract][Full Text] [Related]
15. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827 [TBL] [Abstract][Full Text] [Related]
16. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity. Yun CO; Yoon AR; Yoo JY; Kim H; Kim M; Ha T; Kim GE; Kim H; Kim JH Hum Gene Ther; 2005 Feb; 16(2):248-61. PubMed ID: 15761264 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses. Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939 [TBL] [Abstract][Full Text] [Related]
18. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Alberti MO; Deshane JS; Chaplin DD; Pereboeva L; Curiel DT; Roth JC Gene Ther; 2013 Jul; 20(7):733-41. PubMed ID: 23171918 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653 [TBL] [Abstract][Full Text] [Related]